» Related Searches: cancer, lung cancer, breast cancer, prostate cancer, cancer patients
The National Institute for Health and Clinical Excellence has issued appraisal
consultation documents on Tarceva (erlotinib) and Alimat (pemetrexed) for the
treatment of non-small-cell lung cancer, recommending neither drug … 